Subcommittee for Dose Reconstruction Reviews (SDRR), Advisory Board on Radiation and Worker Health (ABRWH, or Advisory Board), National Institute for Occupational Safety and Health (NIOSH), 53589 [E7-18417]
Download as PDF
<![CDATA[
Federal Register / Vol. 72, No. 181 / Wednesday, September 19, 2007 / Notices
Dated: September 13, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–18485 Filed 9–18–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Subcommittee for Dose
Reconstruction Reviews (SDRR),
Advisory Board on Radiation and
Worker Health (ABRWH, or Advisory
Board), National Institute for
Occupational Safety and Health
(NIOSH)
rwilkins on PROD1PC63 with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting for the
aforementioned committee and
subcommittee:
Subcommittee Meeting Time and Date: 9
a.m.–11:30 a.m., October 3, 2007.
Board Meeting Times and Dates: 1 p.m.–
4:30 p.m., October 3, 2007. 9:30 a.m.–5 p.m.,
October 4, 2007. 8:30 a.m.–2:30 p.m., October
5, 2007.
Public Comment Times and Dates: 5 p.m.–
6 p.m., October 3, 2007.
7:30 p.m.–8:30 p.m., October 4, 2007.
Place: Holiday Inn Select, 1801 N. Naper
Blvd, Naperville, Illinois 60563. Telephone
630.505.4900, Fax 630.505.1984.
Status: Open to the public, limited only by
the space available. The meeting space
accommodates approximately 75 to 100
people.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation Program
(EEOICP) Act of 2000 to advise the President
on a variety of policy and technical functions
required to implement and effectively
manage the new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines which
have been promulgated by the Department of
Health and Human Services (HHS) as a final
rule, advice on methods of dose
reconstruction which have also been
promulgated by HHS as a final rule, advice
on the scientific validity and quality of dose
estimation and reconstruction efforts being
performed for purposes of the compensation
program, and advice on petitions to add
classes of workers to the Special Exposure
Cohort (SEC).
In December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS, which
subsequently delegated this authority to the
CDC. NIOSH implements this responsibility
for CDC. The charter was issued on August
VerDate Aug<31>2005
18:06 Sep 18, 2007
Jkt 211001
3, 2001, renewed at appropriate intervals,
and will expire on August 3, 2009.
Purpose: This Advisory Board is charged
with (a) Providing advice to the Secretary,
HHS, on the development of guidelines
under Executive Order 13179; (b) providing
advice to the Secretary, HHS, on the
scientific validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at any
Department of Energy facility who were
exposed to radiation but for whom it is not
feasible to estimate their radiation dose, and
on whether there is reasonable likelihood
that such radiation doses may have
endangered the health of members of this
class.
Matters To Be Discussed: The topics for the
Subcommittee meeting will be to Review the
Dose Reconstruction and Future
Subcommittee Plan Actions. The agenda for
the Advisory Board meeting includes
Discussion on NIOSH Web site; Update on
Science Issues; Discussion of Board
Procedures; Discussion of the overall tracking
system for Board activities; SEC Petitions to
be considered for Y–12, Hanford, Sandia
National Lab-Livermore, Nuclear Materials
and Equipment Corporation (NUMEC); Work
Group Updates; Planning for Board Future
Activities; SEC Petitions Updates including
Blockson Chemical, Fernald, Chapman
Valve, Dow Chemical, and Bethlehem Steel;
Update on Rocky Flats Follow Up Actions;
Plans to Procure Board Contractors for FY09,
and Agency Updates.
The agenda is subject to change as
priorities dictate.
In the event an individual cannot attend,
written comments may be submitted. Any
written comments received will be provided
at the meeting and should be submitted to
the contact person below well in advance of
the meeting.
For Further Information Contact: Dr. Lewis
V. Wade, Executive Secretary, NIOSH, CDC,
4676 Columbia Parkway, Cincinnati, Ohio
45226, Telephone 513.533.6825, Fax
513.533.6826.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: September 12, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–18417 Filed 9–18–07; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
53589
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center For Research
Resources; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Research Resources Initial Review Group,
Clinical, Research Review Committee. CRRC–
Parent Meeting.
Date: October 16, 2007.
Time: 1 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Democracy Blvd., Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Mohan Viswanathan, PhD,
Deputy Director, National Center For
Research Resources, OR, National Institutes
of Health, 6701 Democracy Blvd., 1
Democracy Plaza, Room 1084, MSC 4874,
Bethesda, MD 20892–4874, 301–435–0829,
mv10f@nih.gov.
Name of Committee: National Center for
Research Resources Initial Review Group,
Research Centers in Minority Institutions and
Institutional Development Award Review
Committee. RIRG–M Parent Meeting.
Date: October 23–24, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Executive Meeting
Center Bethesda, 8120 Wisconsin Ave,
Bethesda, MD 20814.
Contact Person: Linda C. Duffy, PhD,
Scientific Review Administrator, Office of
Review, National Center For Research
Resources, National Institutes of Health, 6701
Dem. Blvd., 1 Dem. Plaza, Rm. 1082, MSC
4874, Bethesda, MD 20892–4874, 301–435–
0810, duffy@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research; 93.371, Biomedical
Technology; 93.389, Research Infrastructure,
93.306, 93.333, National Institutes of Health,
HHS).
E:\FR\FM\19SEN1.SGM
19SEN1
]]>Agencies
[Federal Register Volume 72, Number 181 (Wednesday, September 19, 2007)]
[Notices]
[Page 53589]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-18417]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Subcommittee for Dose Reconstruction Reviews (SDRR), Advisory
Board on Radiation and Worker Health (ABRWH, or Advisory Board),
National Institute for Occupational Safety and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting for the aforementioned
committee and subcommittee:
Subcommittee Meeting Time and Date: 9 a.m.-11:30 a.m., October
3, 2007.
Board Meeting Times and Dates: 1 p.m.-4:30 p.m., October 3,
2007. 9:30 a.m.-5 p.m., October 4, 2007. 8:30 a.m.-2:30 p.m.,
October 5, 2007.
Public Comment Times and Dates: 5 p.m.-6 p.m., October 3, 2007.
7:30 p.m.-8:30 p.m., October 4, 2007.
Place: Holiday Inn Select, 1801 N. Naper Blvd, Naperville,
Illinois 60563. Telephone 630.505.4900, Fax 630.505.1984.
Status: Open to the public, limited only by the space available.
The meeting space accommodates approximately 75 to 100 people.
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program (EEOICP) Act of
2000 to advise the President on a variety of policy and technical
functions required to implement and effectively manage the new
compensation program. Key functions of the Advisory Board include
providing advice on the development of probability of causation
guidelines which have been promulgated by the Department of Health
and Human Services (HHS) as a final rule, advice on methods of dose
reconstruction which have also been promulgated by HHS as a final
rule, advice on the scientific validity and quality of dose
estimation and reconstruction efforts being performed for purposes
of the compensation program, and advice on petitions to add classes
of workers to the Special Exposure Cohort (SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to the CDC. NIOSH implements
this responsibility for CDC. The charter was issued on August 3,
2001, renewed at appropriate intervals, and will expire on August 3,
2009.
Purpose: This Advisory Board is charged with (a) Providing
advice to the Secretary, HHS, on the development of guidelines under
Executive Order 13179; (b) providing advice to the Secretary, HHS,
on the scientific validity and quality of dose reconstruction
efforts performed for this program; and (c) upon request by the
Secretary, HHS, advise the Secretary on whether there is a class of
employees at any Department of Energy facility who were exposed to
radiation but for whom it is not feasible to estimate their
radiation dose, and on whether there is reasonable likelihood that
such radiation doses may have endangered the health of members of
this class.
Matters To Be Discussed: The topics for the Subcommittee meeting
will be to Review the Dose Reconstruction and Future Subcommittee
Plan Actions. The agenda for the Advisory Board meeting includes
Discussion on NIOSH Web site; Update on Science Issues; Discussion
of Board Procedures; Discussion of the overall tracking system for
Board activities; SEC Petitions to be considered for Y-12, Hanford,
Sandia National Lab-Livermore, Nuclear Materials and Equipment
Corporation (NUMEC); Work Group Updates; Planning for Board Future
Activities; SEC Petitions Updates including Blockson Chemical,
Fernald, Chapman Valve, Dow Chemical, and Bethlehem Steel; Update on
Rocky Flats Follow Up Actions; Plans to Procure Board Contractors
for FY09, and Agency Updates.
The agenda is subject to change as priorities dictate.
In the event an individual cannot attend, written comments may
be submitted. Any written comments received will be provided at the
meeting and should be submitted to the contact person below well in
advance of the meeting.
For Further Information Contact: Dr. Lewis V. Wade, Executive
Secretary, NIOSH, CDC, 4676 Columbia Parkway, Cincinnati, Ohio
45226, Telephone 513.533.6825, Fax 513.533.6826.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: September 12, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. E7-18417 Filed 9-18-07; 8:45 am]
BILLING CODE 4163-18-P
